Lee Alison P K, Abramowicz Daniel
Department of Nephrology, University Hospital of Antwerp, Edegem, Belgium.
Nephrol Dial Transplant. 2015 Aug;30(8):1285-90. doi: 10.1093/ndt/gfu304. Epub 2014 Oct 4.
The allocation of deceased donor kidneys has become more complex because of the increasing spectrum of donors and recipients age and comorbidities. Several scoring systems have been proposed to evaluate the donor quality of deceased donor kidneys, based on clinical, pathological or combined parameters to predict the risk of renal allograft failure. Nonetheless, besides the dichotomous extended criteria donor (ECD) score, none of the others have been used in clinical practice because of numerous reasons, ranging from lack of robust validation to the technical challenges associated with the evaluation of donor biopsies. Recently, the Kidney Donor Risk Index (KDRI) and Profile Index (KDPI) were introduced in the USA as a refined version of the ECD score. This scoring system is based on 10 donor factors, therefore providing a finely granulated evaluation of donor quality without the need of a kidney biopsy.Here, we review the advantages and drawbacks of the main scoring systems, and we describe the components of the KDRI and KDPI. It is an easily accessible online tool, based solely on donor factors readily available at the moment of the donor offer. Importantly, the KDPI has also been made part of the 'longevity matching' allocation in the USA, where the best kidneys are allocated to the recipients with the longest predicted post-transplant survival. The KDRI should provide us with a robust qualitative evaluation of deceased donor quality, and therefore will probably play a role in deceased donor kidney allocation policies across Europe in the near future. Hopefully, the KDRI and the KDPI should help transplant programmes to better allocate the scarce resource of deceased donor kidneys.
由于供体和受体的年龄范围及合并症不断增加,已故供体肾脏的分配变得更加复杂。已经提出了几种评分系统来评估已故供体肾脏的供体质量,这些系统基于临床、病理或综合参数来预测肾移植失败的风险。然而,除了二分法的扩大标准供体(ECD)评分外,其他评分系统由于种种原因均未在临床实践中应用,这些原因包括缺乏有力的验证,以及与供体活检评估相关的技术挑战。最近,肾脏供体风险指数(KDRI)和概况指数(KDPI)在美国作为ECD评分的改进版本被引入。该评分系统基于10个供体因素,因此无需进行肾脏活检就能对供体质量进行精细评估。在此,我们回顾主要评分系统的优缺点,并描述KDRI和KDPI的组成部分。它是一个易于访问的在线工具,仅基于供体提供时 readily available 的供体因素。重要的是,KDPI也已成为美国“寿命匹配”分配的一部分,即最好的肾脏分配给移植后预测生存期最长的受体。KDRI应该为我们提供对已故供体质量的有力定性评估,因此在不久的将来可能会在欧洲的已故供体肾脏分配政策中发挥作用。希望KDRI和KDPI能帮助移植项目更好地分配稀缺的已故供体肾脏资源。